Financial Performance Highlights

Mitsu Chem Plast Limited reported strong financial results for FY 2025-26, with revenue from operations increasing by 5.4% to ₹350.17 crore (₹35,016.95 lakh) from ₹332.28 crore in the previous year. Net profit surged 115% to ₹15.62 crore (₹1,561.87 lakh) from ₹7.25 crore in FY25, driven by operational improvements and effective cost management. Basic and diluted earnings per share stood at ₹11.50 compared to ₹5.39 in the previous year.

Capital Structure & Corporate Actions

The company successfully completed a rights issue during the period, offering 15.09 lakh partly paid equity shares to existing shareholders in the ratio of one equity share for every eight shares held. The issue raised ₹1,083.86 lakh, with proceeds utilized for repayment of unsecured loans (₹500 lakh), working capital requirements (₹223.07 lakh), and general corporate purposes. The Board recommended a final dividend of ₹0.20 per equity share (2% on face value of ₹10) for both FY25 and FY26, subject to shareholder approval at the AGM.

Operational & Strategic Developments

Mitsu Chem Plast commissioned a new manufacturing unit (Unit 4) at Tarapur, Maharashtra to support growing operational requirements. The company's product portfolio revenue split showed molded industrial packaging contributing 83.88% of revenue (₹29,371.96 lakh), hospital furniture parts at 13.23% (₹4,631.23 lakh), and infrastructure & others at 2.89% (₹1,013.75 lakh). Export revenue stood at ₹355.78 lakh, representing 0.96% of total turnover.

Financial Position & Ratios

The company maintained a healthy financial position with total equity of ₹11,240.69 lakh and reduced borrowings to ₹589.39 lakh (net of cash), improving the gearing ratio to 0.34 from 0.42 in FY25. Key financial ratios showed significant improvement: Return on Net Worth increased to 13.89% (from 7.47%), Debt-Equity Ratio improved to 0.52 (from 0.71), and Net Profit Margin expanded to 4.46% (from 2.18%). Trade receivables stood at ₹634.79 lakh, with undisputed amounts considered good totaling ₹647.07 lakh.

Regulatory Compliance & Governance

The company submitted its Annual Report for FY 2025-26 to BSE Limited pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations. The report included comprehensive disclosures on financials, corporate governance, CSR activities, and a Business Responsibility and Sustainability Report (BRSR). The company maintained strong corporate governance with a board composition of 6 directors (3 executive, 3 independent) and held 4 board meetings during the year.

Exceptional Items & Contingencies

The company recognized an exceptional item of ₹12.33 lakh for the incremental impact of new Labour Codes on gratuity liabilities, resulting from changes in wage definition under the Labour Codes notified by the Government of India. Contingent liabilities totaled ₹2,550.26 lakh, including income tax disputes (₹11.18 lakh), LC/bills under LC (₹1,436.10 lakh), and bank guarantees (₹457.97 lakh).

CSR & ESG Initiatives

CSR expenditure totaled ₹24.46 lakh (including admin expenses of ₹0.75 lakh), focused on promotion of sports (₹5.71 lakh) and healthcare (₹18.00 lakh). ESG initiatives included energy conservation measures, fuel switch from HSD to CNG, Zero Liquid Discharge facilities, and 272 training programs for employees. The company impacted 500+ lives through CSR activities and maintained zero fatalities and data breaches.

Audit & Compliance

Statutory auditors M/s. Gokhale & Sathe provided an unqualified audit report, with audit fees of ₹5.56 lakh paid. The company complied with all applicable statutory requirements and Secretarial Standards during the financial year, with no material orders passed by regulators/courts affecting going concern status and no fraud reported under Section 143(12) of Companies Act.